HUNTER CHESTNUT: Open Payments
NPI 1437785888 · CONWAY, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$607 in 32 payments from 13 companies in 2025. Trend: 2023 $289 · 2024 $161 · 2025 $607
Food & beverage: $607
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 8 | $156 |
| Novo Nordisk Inc | 4 | $100 |
| Lilly USA, LLC | 6 | $84 |
| Madrigal Pharmaceuticals | 1 | $44 |
| ABBVIE INC. | 2 | $35 |
| AstraZeneca Pharmaceuticals LP | 2 | $29 |
| SANOFI-AVENTIS U.S. LLC | 2 | $29 |
| Novartis Pharmaceuticals Corporation | 2 | $28 |
| Sumitomo Pharma America, Inc. | 1 | $27 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $25 |
Products named: Bimzelx, JARDIANCE, Wegovy, REZDIFFRA, Ozempic, TZIELD, GEMTESA, QULIPTA.
Industry payments across SC — which companies pay providers there.
